Literature DB >> 21709779

HPV pseudovirions as DNA delivery vehicles.

Barbara Ma, Richard B S Roden, Chien-Fu Hung, T C Wu.   

Abstract

"The ability of HPV pseudovirions to efficiently deliver DNA into cells suggests several potential applications in basic biology, including the characterization of virion biology and measurement of protective neutralizing antibody titers in vitro and in vivo, as well as their employment for more direct medical applications".

Entities:  

Keywords:  DNA delivery; DNA vaccine; HPV pseudovirions; human papillomavirus; neutralization assay

Mesh：

Substances：

Year:  2011        PMID： 21709779      PMCID： PMC3120056          DOI： 10.4155/tde.11.28

Source DB:  PubMed          Journal:  Ther Deliv        ISSN： 2041-5990


  20 in total

1.  Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae.

Authors:  J L Rossi; L Gissmann; K Jansen; M Müller
Journal:  Hum Gene Ther       Date:  2000-05-20       Impact factor: 5.695

2.  In vitro gene transfer using human papillomavirus-like particles.

Authors:  A Touze; P Coursaget
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

3.  DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1.

Authors:  K N Zhao; X Y Sun; I H Frazer; J Zhou
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

4.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Efficient delivery of DNA vaccines using human papillomavirus pseudovirions.

Authors:  S Peng; A Monie; T H Kang; C-F Hung; R Roden; T-C Wu
Journal:  Gene Ther       Date:  2010-07-29       Impact factor: 5.250

Review 6.  Preventative and therapeutic vaccines for cervical cancer.

Authors:  Richard Roden; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2003-08       Impact factor: 5.217

7.  Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.

Authors:  Patricia M Day; Cynthia D Thompson; Christopher B Buck; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

8.  Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.

Authors:  Patricia M Day; Ratish Gambhira; Richard B S Roden; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

9.  Efficient intracellular assembly of papillomaviral vectors.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.

Authors:  Jeffrey N Roberts; Christopher B Buck; Cynthia D Thompson; Rhonda Kines; Marcelino Bernardo; Peter L Choyke; Douglas R Lowy; John T Schiller
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440
View more
  5 in total

1.  Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.

Authors:  Maxime J J Fleury; Antoine Touzé; Pierre Coursaget
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

2.  DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity.

Authors:  Shiwen Peng; Barbara Ma; Shu-Hsia Chen; Chien-Fu Hung; Tc Wu
Journal:  Cell Biosci       Date:  2011-07-28       Impact factor: 7.133

3.  Compendium of pseudo conditions in sexually transmitted diseases.

Authors:  Balaji Govindan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jan-Jun

4.  Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells.

Authors:  Renate L Lamprecht; Paul Kennedy; Suzanne M Huddy; Susanne Bethke; Megan Hendrikse; Inga I Hitzeroth; Edward P Rybicki
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

Review 5.  Retinoic acid receptor beta promoter methylation and risk of cervical cancer.

Authors:  Chaninya Wongwarangkana; Nasamon Wanlapakorn; Jira Chansaenroj; Yong Poovorawan
Journal:  World J Virol       Date:  2018-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.